Preliminary Detailed Program
Friday, December 13, 2024 |
|
|
IntroductionOndrej Viklicky, Georg Böhmig |
13:10–14:55 |
Infections
Chairs: Ivan Rychlík, Zuzana Žilinská
|
| Roman Reindl-Schwaighofer (Vienna): Vienna COVID-19 experience | |
| 13:40–14:05 | Ivan Zahradka (Prague): COVID-19 in kidney transplant recipients after the pandemic – common cold or looming threat? |
| 14:05–14:30 | Michael Eder (Vienna): Polyoma challenges after recipient desensitization |
| 14:30–14:55 | Tomas Reischig (Plzen): How to improve preemptive therapy approach for CMV prevention in kidney transplant recipients? |
| 14:55–15:20 | Coffee break |
15:20–17:00 |
Recent kidney trials
Chair: Kathrin Eller
|
| 15:20–15:45 | Klemens Budde (Berlin): Donor and recipient age matching? |
| 15:45–16:10 | Frederik Haupenthal (Vienna): Adherence in kidney transplantation |
| 16:10–16:35 | Julie Refardt (Basel): SGLT2 inhibitors in SIADH |
| 16:35–17:00 | Uwe Heemann (Munich): German transplant biopsy study |
19:30 |
Networking Event |
Saturday, December 14, 2024 |
|
08:30–10:10 |
ABMR
Chairs: Georg Böhmig, Klemens Budde
|
| 08:30–08:55 | Helmut Feucht (Munich): History of ABMR |
| 08:55–09:20 | Katharina Mayer (Vienna): Felzartamab in ABMR |
| 09:20–09:45 | Matthias Diebold (Basel): NK cells in transplantation |
| 09:45–10:10 | Ondrej Viklicky (Prague): Molecular diagnostics in HLA incompatible transplantation |
| 10:10–10:30 | Coffee break |
10:30–12:10 |
CKD/IgAN
Chair: Manfred Hecking
|
| 10:30–10:55 | Kathrin Eller (Graz): Diets in glomerulonephritis |
| 10:55–11:20 | Christoph Aigner (Vienna): Complement-mediated Kidney Disease |
| 11:20–11:45 | Vladimir Tesar (Prague): Complement inhibition and IgAN |
| 11:45–12:10 | Milan Raska (Olomouc): Novel aspects of pathogenesis of IgA nephropathy |
| 12:10–13:00 | Lunch |
13:00–14:40 |
Innovations
Chair: Attila J Szabó
|
| 13:00–13:25 | Farsad Eskandary (Vienna): Virus-specific T cell therapy in organ transplantation |
| 13:25–13:50 | Manfred Hecking (Vienna): App-Based, Longitudinal Symptom Assessment in Dialysis |
| 13:50–14:15 | Miha Arnol (Ljubljana): Extracellular vesicles in urine and vesicle-bound DNA for detection of kidney allograft injury |
| 14:15–14:40 | Ivana Dedinska (Martin): Glycemic variability in early post-transplant period |
| 14:40–15:00 | Coffee break |
15:00–16:40 |
Biopsies
Chairs: Marek Kollár, Uwe Heemann
|
| 15:00–15:25 | Zdenka Hruskova (Prague): Non-invasive markers of renal fibrosis? |
| 15:25–15:50 | Johannes Kläger (Vienna): Innovative spatial profiling of kidney biopsies |
| 15:50–16:15 | Petra Hruba (Prague): Molecular diagnostics of deceased donors to identify grafts at risk |
| 16:15–16:40 | Thomas Schachtner (Zürich): MMDx experience |
16:40 |
Conclusion and AdjournGeorg Böhmig, Ondrej Viklicky |
